Skip to content
10-Q

Quarterly Report

Kyverna Therapeutics, Inc. KYTX

0001193125-25-277584

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 43.8M sh
Shares Diluted Q3 2025 · Sep 30, 2025 43.42M sh
Shares Diluted Q3 2025 · Sep 30, 2025 43.28M sh
Shares Diluted Q3 2025 · Sep 30, 2024 43.16M sh
Shares Diluted Q3 2025 · Sep 30, 2024 36.7M sh
Capex Q3 2025 · Sep 30, 2025 $6K
Capex Q3 2025 · Sep 30, 2024 $1.67M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$120.19M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$77.19M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $34.16M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $96.62M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $104.66M
Stockholders Equity Q3 2025 · Sep 30, 2025 $151.95M
Stockholders Equity Q3 2025 · Jun 30, 2025 $184.38M
Stockholders Equity Q3 2025 · Mar 31, 2025 $224.01M
Stockholders Equity Q3 2025 · Dec 31, 2024 $266.59M
Stockholders Equity Q3 2025 · Sep 30, 2024 $302.71M
Stockholders Equity Q3 2025 · Jun 30, 2024 $333.51M
Stockholders Equity Q3 2025 · Mar 31, 2024 $360.99M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$131.4M
Current Liabilities Q3 2025 · Sep 30, 2025 $33.87M
Current Liabilities Q3 2025 · Dec 31, 2024 $33.76M
Total Liabilities Q3 2025 · Sep 30, 2025 $35.21M
Total Liabilities Q3 2025 · Dec 31, 2024 $38.06M
Current Assets Q3 2025 · Sep 30, 2025 $174.93M
Current Assets Q3 2025 · Dec 31, 2024 $290.6M
Total Assets Q3 2025 · Sep 30, 2025 $187.16M
Total Assets Q3 2025 · Dec 31, 2024 $304.65M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.85
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.85
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.80
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.45
Eps Basic Q3 2025 · Sep 30, 2025 −$0.85
Eps Basic Q3 2025 · Sep 30, 2025 −$2.85
Eps Basic Q3 2025 · Sep 30, 2024 −$0.80
Eps Basic Q3 2025 · Sep 30, 2024 −$2.45
Sga Expense Q3 2025 · Sep 30, 2025 $8.27M
Sga Expense Q3 2025 · Sep 30, 2025 $26.84M
Sga Expense Q3 2025 · Sep 30, 2024 $9.58M
Sga Expense Q3 2025 · Sep 30, 2024 $22.57M
Rd Expense Q3 2025 · Sep 30, 2025 $30.46M
Rd Expense Q3 2025 · Sep 30, 2025 $103.71M
Rd Expense Q3 2025 · Sep 30, 2024 $29.19M
Rd Expense Q3 2025 · Sep 30, 2024 $78.99M
Net Income Q3 2025 · Sep 30, 2025 −$36.79M
Net Income Q3 2025 · Sep 30, 2025 −$123.5M
Net Income Q3 2025 · Jun 30, 2025 −$42.08M
Net Income Q3 2025 · Mar 31, 2025 −$44.64M
Net Income Q3 2025 · Sep 30, 2024 −$34.49M
Net Income Q3 2025 · Sep 30, 2024 −$89.99M
Net Income Q3 2025 · Jun 30, 2024 −$28.8M
Net Income Q3 2025 · Mar 31, 2024 −$26.69M
Operating Income Q3 2025 · Sep 30, 2025 −$38.73M
Operating Income Q3 2025 · Sep 30, 2025 −$130.55M
Operating Income Q3 2025 · Sep 30, 2024 −$38.77M
Operating Income Q3 2025 · Sep 30, 2024 −$101.56M